APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Serum and Plasma

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Serum and Plasma Market Outlook and Growth Opportunities 2026

27 December 2025191 pages

Choose your research edition.

Industry ResearchHuman Serum and Plasma Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Serum and Plasma Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Human Serum and Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Serum and Plasma Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Serum and Plasma Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Human Serum and Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Serum and Plasma market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Serum and Plasma market include Thermo Fisher, Merck Millipore, Baxter, Zen-Bio, Trina Bioreactives, TCS Biosciences Ltd, SeraCare, Monobind and Cytiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Serum and Plasma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Serum and Plasma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Serum and Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Serum and Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Serum and Plasma Segment by Company

Thermo Fisher

Merck Millipore

Baxter

Zen-Bio

Trina Bioreactives

TCS Biosciences Ltd

SeraCare

Monobind

Cytiva

Akron

Human Serum and Plasma Segment by Type

Fresh Human Serum and Plasma

Frozen Human Serum and Plasma

Human Serum and Plasma Segment by Application

Vaccines and Antibodies

Cell Culture

In Vitro Diagnostics

Clinical Research

Others

Human Serum and Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Serum and Plasma status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Serum and Plasma market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Serum and Plasma significant trends, drivers, influence factors in global and regions.

6. To analyze Human Serum and Plasma competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum and Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Serum and Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Serum and Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Serum and Plasma market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Serum and Plasma industry.

Chapter 3: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Serum and Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Serum and Plasma in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Serum and Plasma Industry Trends Table 2. Human Serum and Plasma Industry Drivers Table 3. Human Serum and Plasma Industry Opportunities and Challenges Table 4. Human Serum and Plasma Industry Restraints Table 5. Global Human Serum and Plasma Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Serum and Plasma Revenue Share by Company (2021-2026) Table 7. Global Human Serum and Plasma Sales Volume by Company (Units) & (2021-2026) Table 8. Global Human Serum and Plasma Sales Volume Share by Company (2021-2026) Table 9. Global Human Serum and Plasma Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Human Serum and Plasma Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Serum and Plasma Key Company Manufacturing Base & Headquarters Table 12. Global Human Serum and Plasma Company, Product Type & Application Table 13. Global Human Serum and Plasma Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Serum and Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fresh Human Serum and Plasma Table 18. Significant Companies of Frozen Human Serum and Plasma Table 19. Global Human Serum and Plasma Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Human Serum and Plasma Sales Volume by Type (2021-2026) & (Units) Table 21. Global Human Serum and Plasma Sales Volume by Type (2027-2032) & (Units) Table 22. Global Human Serum and Plasma Sales Volume Share by Type (2021-2026) Table 23. Global Human Serum and Plasma Sales Volume Share by Type (2027-2032) Table 24. Global Human Serum and Plasma Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Human Serum and Plasma Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Human Serum and Plasma Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Human Serum and Plasma Sales Value Share by Type (2021-2026) Table 28. Global Human Serum and Plasma Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Vaccines and Antibodies Table 30. Significant Companies of Cell Culture Table 31. Significant Companies of In Vitro Diagnostics Table 32. Significant Companies of Clinical Research Table 33. Significant Companies of Others Table 34. Global Human Serum and Plasma Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Human Serum and Plasma Sales Volume by Application (2021-2026) & (Units) Table 36. Global Human Serum and Plasma Sales Volume by Application (2027-2032) & (Units) Table 37. Global Human Serum and Plasma Sales Volume Share by Application (2021-2026) Table 38. Global Human Serum and Plasma Sales Volume Share by Application (2027-2032) Table 39. Global Human Serum and Plasma Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Human Serum and Plasma Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Human Serum and Plasma Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Human Serum and Plasma Sales Value Share by Application (2021-2026) Table 43. Global Human Serum and Plasma Sales Value Share by Application (2027-2032) Table 44. Global Human Serum and Plasma Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Human Serum and Plasma Sales by Region (2021-2026) & (Units) Table 46. Global Human Serum and Plasma Sales Market Share by Region (2021-2026) Table 47. Global Human Serum and Plasma Sales by Region (2027-2032) & (Units) Table 48. Global Human Serum and Plasma Sales Market Share by Region (2027-2032) Table 49. Global Human Serum and Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Human Serum and Plasma Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Human Serum and Plasma Sales Value Share by Region (2021-2026) Table 52. Global Human Serum and Plasma Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Human Serum and Plasma Sales Value Share by Region (2027-2032) Table 54. Global Human Serum and Plasma Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Human Serum and Plasma Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Human Serum and Plasma Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 59. Global Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 60. Global Human Serum and Plasma Sales by Country (2027-2032) & (Units) Table 61. Global Human Serum and Plasma Sales Market Share by Country (2027-2032) Table 62. Global Human Serum and Plasma Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Human Serum and Plasma Sales Value Market Share by Country (2021-2026) Table 64. Global Human Serum and Plasma Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Human Serum and Plasma Sales Value Market Share by Country (2027-2032) Table 66. Thermo Fisher Company Information Table 67. Thermo Fisher Business Overview Table 68. Thermo Fisher Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Thermo Fisher Human Serum and Plasma Product Portfolio Table 70. Thermo Fisher Recent Development Table 71. Merck Millipore Company Information Table 72. Merck Millipore Business Overview Table 73. Merck Millipore Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Millipore Human Serum and Plasma Product Portfolio Table 75. Merck Millipore Recent Development Table 76. Baxter Company Information Table 77. Baxter Business Overview Table 78. Baxter Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Baxter Human Serum and Plasma Product Portfolio Table 80. Baxter Recent Development Table 81. Zen-Bio Company Information Table 82. Zen-Bio Business Overview Table 83. Zen-Bio Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zen-Bio Human Serum and Plasma Product Portfolio Table 85. Zen-Bio Recent Development Table 86. Trina Bioreactives Company Information Table 87. Trina Bioreactives Business Overview Table 88. Trina Bioreactives Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Trina Bioreactives Human Serum and Plasma Product Portfolio Table 90. Trina Bioreactives Recent Development Table 91. TCS Biosciences Ltd Company Information Table 92. TCS Biosciences Ltd Business Overview Table 93. TCS Biosciences Ltd Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. TCS Biosciences Ltd Human Serum and Plasma Product Portfolio Table 95. TCS Biosciences Ltd Recent Development Table 96. SeraCare Company Information Table 97. SeraCare Business Overview Table 98. SeraCare Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. SeraCare Human Serum and Plasma Product Portfolio Table 100. SeraCare Recent Development Table 101. Monobind Company Information Table 102. Monobind Business Overview Table 103. Monobind Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Monobind Human Serum and Plasma Product Portfolio Table 105. Monobind Recent Development Table 106. Cytiva Company Information Table 107. Cytiva Business Overview Table 108. Cytiva Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Cytiva Human Serum and Plasma Product Portfolio Table 110. Cytiva Recent Development Table 111. Akron Company Information Table 112. Akron Business Overview Table 113. Akron Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Akron Human Serum and Plasma Product Portfolio Table 115. Akron Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Human Serum and Plasma Distributors List Table 119. Human Serum and Plasma Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Human Serum and Plasma Product Image Figure 2. Global Human Serum and Plasma Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Serum and Plasma Sales (2021-2032) & (Units) Figure 5. Global Human Serum and Plasma Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Human Serum and Plasma Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fresh Human Serum and Plasma Image Figure 10. Frozen Human Serum and Plasma Image Figure 11. Global Human Serum and Plasma Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Human Serum and Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Human Serum and Plasma Sales Volume Share by Type (2021-2032) Figure 14. Global Human Serum and Plasma Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Human Serum and Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Human Serum and Plasma Sales Value Share by Type (2021-2032) Figure 17. Vaccines and Antibodies Image Figure 18. Cell Culture Image Figure 19. In Vitro Diagnostics Image Figure 20. Clinical Research Image Figure 21. Others Image Figure 22. Global Human Serum and Plasma Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Human Serum and Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Human Serum and Plasma Sales Volume Share by Application (2021-2032) Figure 25. Global Human Serum and Plasma Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Human Serum and Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Human Serum and Plasma Sales Value Share by Application (2021-2032) Figure 28. Global Human Serum and Plasma Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Human Serum and Plasma Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Human Serum and Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Human Serum and Plasma Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 33. North America Human Serum and Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Human Serum and Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Human Serum and Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 39. South America Human Serum and Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Human Serum and Plasma Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Human Serum and Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Human Serum and Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Human Serum and Plasma Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Human Serum and Plasma Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Fresh Human Serum and Plasma
  • Frozen Human Serum and Plasma
Applications
  • Vaccines and Antibodies
  • Cell Culture
  • In Vitro Diagnostics
  • Clinical Research
  • Others
Companies covered
  • Thermo Fisher
  • Merck Millipore
  • Baxter
  • Zen-Bio
  • Trina Bioreactives
  • TCS Biosciences Ltd
  • SeraCare
  • Monobind
  • Cytiva
  • Akron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Serum and Plasma Sales Value (2021-2032)
  4. 1.2.2 Global Human Serum and Plasma Sales Volume (2021-2032)
  5. 1.2.3 Global Human Serum and Plasma Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Serum and Plasma Market Dynamics
  1. 2.1 Human Serum and Plasma Industry Trends
  2. 2.2 Human Serum and Plasma Industry Drivers
  3. 2.3 Human Serum and Plasma Industry Opportunities and Challenges
  4. 2.4 Human Serum and Plasma Industry Restraints
3 Human Serum and Plasma Market by Company
  1. 3.1 Global Human Serum and Plasma Company Revenue Ranking in 2025
  2. 3.2 Global Human Serum and Plasma Revenue by Company (2021-2026)
  3. 3.3 Global Human Serum and Plasma Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Serum and Plasma Average Price by Company (2021-2026)
  5. 3.5 Global Human Serum and Plasma Company Ranking (2024-2026)
  6. 3.6 Global Human Serum and Plasma Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Serum and Plasma Company Product Type and Application
  8. 3.8 Global Human Serum and Plasma Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Serum and Plasma Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Serum and Plasma Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Serum and Plasma Market by Type
  1. 4.1 Human Serum and Plasma Type Introduction
  2. 4.1.1 Fresh Human Serum and Plasma
  3. 4.1.2 Frozen Human Serum and Plasma
  4. 4.2 Global Human Serum and Plasma Sales Volume by Type
  5. 4.2.1 Global Human Serum and Plasma Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Serum and Plasma Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Human Serum and Plasma Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Human Serum and Plasma Sales Value by Type
  9. 4.3.1 Global Human Serum and Plasma Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Serum and Plasma Sales Value by Type (2021-2032)
  11. 4.3.3 Global Human Serum and Plasma Sales Value Share by Type (2021-2032)
5 Human Serum and Plasma Market by Application
  1. 5.1 Human Serum and Plasma Application Introduction
  2. 5.1.1 Vaccines and Antibodies
  3. 5.1.2 Cell Culture
  4. 5.1.3 In Vitro Diagnostics
  5. 5.1.4 Clinical Research
  6. 5.1.5 Others
  7. 5.2 Global Human Serum and Plasma Sales Volume by Application
  8. 5.2.1 Global Human Serum and Plasma Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Human Serum and Plasma Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Human Serum and Plasma Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Human Serum and Plasma Sales Value by Application
  12. 5.3.1 Global Human Serum and Plasma Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Human Serum and Plasma Sales Value by Application (2021-2032)
  14. 5.3.3 Global Human Serum and Plasma Sales Value Share by Application (2021-2032)
6 Human Serum and Plasma Regional Sales and Value Analysis
  1. 6.1 Global Human Serum and Plasma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Serum and Plasma Sales by Region (2021-2032)
  3. 6.2.1 Global Human Serum and Plasma Sales by Region: 2021-2026
  4. 6.2.2 Global Human Serum and Plasma Sales by Region (2027-2032)
  5. 6.3 Global Human Serum and Plasma Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Serum and Plasma Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Serum and Plasma Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Serum and Plasma Sales Value by Region (2027-2032)
  9. 6.5 Global Human Serum and Plasma Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Serum and Plasma Sales Value (2021-2032)
  12. 6.6.2 North America Human Serum and Plasma Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Serum and Plasma Sales Value (2021-2032)
  15. 6.7.2 Europe Human Serum and Plasma Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Serum and Plasma Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Serum and Plasma Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Serum and Plasma Sales Value (2021-2032)
  21. 6.9.2 South America Human Serum and Plasma Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Serum and Plasma Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Serum and Plasma Sales Value Share by Country, 2025 VS 2032
7 Human Serum and Plasma Country-level Sales and Value Analysis
  1. 7.1 Global Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Serum and Plasma Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Serum and Plasma Sales by Country (2021-2032)
  4. 7.3.1 Global Human Serum and Plasma Sales by Country (2021-2026)
  5. 7.3.2 Global Human Serum and Plasma Sales by Country (2027-2032)
  6. 7.4 Global Human Serum and Plasma Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Serum and Plasma Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Serum and Plasma Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Serum and Plasma Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Serum and Plasma Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Serum and Plasma Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher
  2. 8.1.1 Thermo Fisher Company Information
  3. 8.1.2 Thermo Fisher Business Overview
  4. 8.1.3 Thermo Fisher Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Human Serum and Plasma Product Portfolio
  6. 8.1.5 Thermo Fisher Recent Developments
  7. 8.2 Merck Millipore
  8. 8.2.1 Merck Millipore Company Information
  9. 8.2.2 Merck Millipore Business Overview
  10. 8.2.3 Merck Millipore Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Millipore Human Serum and Plasma Product Portfolio
  12. 8.2.5 Merck Millipore Recent Developments
  13. 8.3 Baxter
  14. 8.3.1 Baxter Company Information
  15. 8.3.2 Baxter Business Overview
  16. 8.3.3 Baxter Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Human Serum and Plasma Product Portfolio
  18. 8.3.5 Baxter Recent Developments
  19. 8.4 Zen-Bio
  20. 8.4.1 Zen-Bio Company Information
  21. 8.4.2 Zen-Bio Business Overview
  22. 8.4.3 Zen-Bio Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zen-Bio Human Serum and Plasma Product Portfolio
  24. 8.4.5 Zen-Bio Recent Developments
  25. 8.5 Trina Bioreactives
  26. 8.5.1 Trina Bioreactives Company Information
  27. 8.5.2 Trina Bioreactives Business Overview
  28. 8.5.3 Trina Bioreactives Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Trina Bioreactives Human Serum and Plasma Product Portfolio
  30. 8.5.5 Trina Bioreactives Recent Developments
  31. 8.6 TCS Biosciences Ltd
  32. 8.6.1 TCS Biosciences Ltd Company Information
  33. 8.6.2 TCS Biosciences Ltd Business Overview
  34. 8.6.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 TCS Biosciences Ltd Human Serum and Plasma Product Portfolio
  36. 8.6.5 TCS Biosciences Ltd Recent Developments
  37. 8.7 SeraCare
  38. 8.7.1 SeraCare Company Information
  39. 8.7.2 SeraCare Business Overview
  40. 8.7.3 SeraCare Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SeraCare Human Serum and Plasma Product Portfolio
  42. 8.7.5 SeraCare Recent Developments
  43. 8.8 Monobind
  44. 8.8.1 Monobind Company Information
  45. 8.8.2 Monobind Business Overview
  46. 8.8.3 Monobind Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Monobind Human Serum and Plasma Product Portfolio
  48. 8.8.5 Monobind Recent Developments
  49. 8.9 Cytiva
  50. 8.9.1 Cytiva Company Information
  51. 8.9.2 Cytiva Business Overview
  52. 8.9.3 Cytiva Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cytiva Human Serum and Plasma Product Portfolio
  54. 8.9.5 Cytiva Recent Developments
  55. 8.10 Akron
  56. 8.10.1 Akron Company Information
  57. 8.10.2 Akron Business Overview
  58. 8.10.3 Akron Human Serum and Plasma Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Akron Human Serum and Plasma Product Portfolio
  60. 8.10.5 Akron Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Serum and Plasma Value Chain Analysis
  2. 9.1.1 Human Serum and Plasma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Serum and Plasma Sales Mode & Process
  6. 9.2 Human Serum and Plasma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Serum and Plasma Distributors
  9. 9.2.3 Human Serum and Plasma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst